| GTO ID | GTC1688 |
| Trial ID | NCT03030001 |
| Disease | Advanced Cancer |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MESO CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies |
| Year | 2017 |
| Country | China |
| Company sponsor | Ningbo Cancer Hospital |
| Other ID(s) | H2017-01-P01 |
| Cohort 1 | |||||||||
|
|||||||||